TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/10/24 17:55 | 6/7/24 | MXCT | Maxcyte, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P.m | 489 | 4.89 | 0 | 100 | 100 | D | |||||||||||||||
5/28/24 17:55 | 3/22/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 5 | P.d | 3,890 | 4.83 | 0 | 805 | 29 | 3,537 | D | ||||||||||||||
3/5/24 21:30 | 3/1/24 | ABSI | Absci Corp | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P | 1,000 | 4.50 | 0 | 222 | 3 | 8,253 | I | |||||||||||||||
1/25/24 16:19 | 6/7/19 | NOTV | Inotiv, Inc. | IN | Health | Biolab | Commercial Physical & Biologi | 3 | 3 | P.d | 179 | 2.96 | 0 | 60 | 28 | 275 | I | ||||||||||||||
12/26/23 09:00 | 12/21/23 | RNGE | Range Impact, Inc. | NV | Health | Biolab | Commercial Physical & Biologi | 4 | 6 | P.dm | 1,267 | 0.1214 | 0 | 10,440 | 21 | 59,731 | D | ||||||||||||||
11/21/23 17:07 | 11/20/23 | CRL | Charles River Laboratories International, Inc. | Health | Biolab | Commercial Physical & Biologi | 3 | 3 | P | 1,448 | 182.29 | 0 | 8 | 3 | 319 | D | |||||||||||||||
9/15/23 16:23 | 9/14/23 | ISPC | Ispecimen Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P | 13 | 0.7200 | 0 | 18 | 27 | 84 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |